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Replacement of dichloromethane as the bulk medium within
chromatographic puriﬁcation has been evaluated with a
broad range of molecules containing functionality common
within Medicinal Chemistry programmes. Analysis of the
data set has generated a set of general guidelines to assist in
the selection of alternative solvents for CH2Cl2 as the bulk
media in these ubiquitously employed processes.
Replacement of hazardous solvents in order to achieve greater
sustainability and/or to reduce both environmental and oper-
ational costs is a key emerging consideration within the pharma-
ceutical industry.1 A number of reports have recently emerged
from leading pharmaceutical companies detailing the drivers and
requirements for increasing the sustainability of their overall pro-
cesses through adoption of green chemistry principles and,
indeed, have signposted a change in solvent selection as a
primary method of achieving this.1–3 In particular, chlorinated
solvents such as CH2Cl2 and CHCl3 are two common solvents
of routine and widespread use that possess signiﬁcant hazardous
toxicity to both humans and the environment and which require
more careful and costly disposal.4 Consequently, there is a strong
desire to supplant these systems with more benign alternatives.
In relation to this, puriﬁcation is by far the largest consumer
of solvent within any synthetically aligned research programme.
Indeed in the context of pharmaceutical research, on average
solvent has been estimated to constitute some 56% of the total
material used to manufacture active pharmaceutical ingre-
dients.2a Accordingly, moving to a more environmentally conser-
vative solvent selection within chromatographic puriﬁcation
could therefore be expected to have the largest single impact on
the overall sustainability of chemical synthesis endeavours.
However, while this may seem reasonably straightforward in
principle, the lack of solid data in this area presents a barrier to
the general adoption of these more environmentally acceptable
approaches.
Equielutropic series have been constructed for a range of con-
ventional solvents,5 however, these are heavily skewed towards
solvents with major regulatory and/or toxicological issues, for
example chlorinated, toluene, hexane. This is presumably due to
sustainability not being a primary concern during the time
period in which this analysis was conducted (in the 1960s). As
such, little equivalent data exists for alternative solvents with
fewer issues that can be employed as replacements.
Having said this, a very recent contribution in this area from
Amgen has endeavoured to provide a guide to alternative solvent
selection for replacement of CH2Cl2 in puriﬁcation.
3 This excel-
lent study has focused on the use of alcohol-(MeOH, EtOH,
i-PrOH) and additive-modiﬁed (AcOH, NH4OH) mixtures of
heptanes, EtOAc, and tert-butyl methyl ether (TBME) for the
puriﬁcation of a range of 26 drug-like molecules and has pres-
ented a modern equielutropic series based on these mixtures in
comparison to MeOH–CH2Cl2.
In a complementary approach, we recently sought to generate
speciﬁc and comprehensive data to assist in the selection of
alternative solvents as replacements for CH2Cl2 within chroma-
tographic puriﬁcation using binary eluent systems. The current
study will greatly assist in the selection of greener alternative
eluents and we believe will help facilitate widespread adoption




Our approach towards identifying potential replacements for
chlorinated solvents, particularly CH2Cl2, in puriﬁcation was
based on thin layer chromatography (TLC) analysis. This was
similar to the approach taken by Neher in 1964 (the approach
that led to the original equielutropic series)5 and to that recently
adopted by Amgen.3 To ensure the greatest opportunity for adop-
tion of any developed method, we focused primarily on binary
eluent mixtures comprising of a bulk solvent modiﬁed by MeOH
(or i-PrOH, vide infra) as we believed that these would be more
convenient to the practicing chemist. Each compound from our
selected library would be analysed by TLC at various
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compositions of modiﬁer : bulk medium with analyses per-
formed in triplicate to ensure reproducibility.
To initiate our study, we ﬁrst selected a range of small lead-
like molecules that displayed broad coverage of the functional
group landscape. In addition to this and in attempts to ensure our
data was as applicable and relevant as possible, we also selected
a range of structurally more complex molecules, several of
which were previously marketed drug molecules and others
which had been prepared as part of on-going academic medicinal
chemistry projects.6 In total, we surveyed 95 compounds – 74
fragment-like moieties and 21 larger, drug-related molecules
(sets 1 and 2, respectively, Fig. 1).
To ensure our data set was as realistic and as representative as
possible, we performed principal component analysis (PCA) of
the 95 compounds based on six descriptors:7 (i) molecular
weight (94–822); (ii) number of hydrogen bond donors (0–6);
(iii) number of hydrogen bond acceptors (0–12); (iv) number of
rotatable bonds (0–14); (v) XlogP (−1.7 to 3.2); and (vi) polar
surface area (12–220 Å2). A scatter diagram of this analysis
(Fig. 2) clearly suggests diverse coverage of the chemical land-
scape: the x-axis (PCA dimension 0) is mainly a function of
molecular weight and polar descriptors while the y-axis (PCA
dimension 1) is mainly a lipophilicity descriptor. Inspection of
the data suggests that there is a slight bias for the lower
Fig. 1 Compound library evaluated.‡































































molecular weight side of the scatter graph. This is likely to be a
consequence of the majority of low molecular weight com-
pounds (63 compounds in the molecular weight range 94–221),
although, having stated this, there is still an excellent distribution
of molecular properties within the data set and these compounds
are more likely to be of relevance within a pharmaceutical
research and development setting.
In terms of the alternative bulk media, we decided to employ
several emerging or existing solvents to use in conjunction with
the modiﬁer. Speciﬁcally, we evaluated cyclopentyl methyl ether
(CPME),8 TBME, 2-methyl tetrahydrofuran (2-MeTHF),
dimethyl carbonate (DMC), and EtOAc. For the modiﬁer, with
the exception of EtOAc, we elected to use MeOH as it is one of
the most widely used modiﬁers for polar compound chromato-
graphy and would enable a direct comparison with MeOH–
CH2Cl2 mixtures. For EtOAc, i-PrOH was employed as the
modiﬁer based on emerging and promising data for this binary
eluent.9 In addition, the Amgen group assessed MeOH–EtOAc
mixtures in their recent study and had compared this to MeOH–
CH2Cl2.
3 Overall, this would provide ﬁve different binary eluent
systems to compare with MeOH–CH2Cl2 mixtures.
Analysis
A representative combined chart with Rf plotted against %
modiﬁer for each of the six solvent systems for compound 89 is
shown in Fig. 3. Equivalent data was generated for all 95 com-
pounds with the associated error in average Rf values remaining
consistently very low. We also observed reliably excellent linear
correlation throughout the data sets, with R2 values of >0.95.
With the data in hand, we sought to establish trends with
which to form the basis for guidelines to direct use of these
alternative eluent systems. A useful analysis of the data set was
achieved through a simple box plot. Fig. 4 shows a box plot of
Rf (y-axis) vs. 10% modiﬁer in each of the bulk media (Table 1
displays the Rf ranges and medians for each eluent). We also
conducted the same box plot analysis for the 5% and 20%
modiﬁer levels and achieved similar distributions. This analysis
gives a usefully condensed assessment of the Rf data for each of
the eluent mixtures. The relative distribution of the data for the
95 compounds and for each of the binary mixtures can be clearly
seen: each of the four quadrants indicates that 25% of the com-
pounds can be found within that particular Rf range.
Firstly, the data for MeOH–CH2Cl2 was spread reasonably
well and with relatively good quadrant consistency over the Rf
range: each of the data quadrants was of comparable magnitude
and the data range covers the Rf range 0.01–88, although there
was a noted slight bias for the lower end of the Rf range (median
Rf = 0.41). Comparing the data for the other ﬁve alternative
eluent systems, the following observations can be made: (i) The
data for the CPME-based system was excellent and, in fact, this
analysis suggests that the CPME data is actually superior to the
CH2Cl2 system, as the quadrants were more homogenous
(median = Rf 0.50) and the dynamic Rf range was wider
Fig. 2 PCA of the 95-substrate set.‡
Fig. 3 Illustrative graph of eluent evaluation.‡
Fig. 4 Box plot analysis of Rf vs. eluent at 10% modiﬁer level.‡
Table 1 Rf ranges and medians for box plot analysis in Fig. 4
a‡
Entry Eluent Rf range Median
1 MeOH–CH2Cl2 0.01–0.88 0.41
2 MeOH–CPME 0.02–0.94 0.50
3 MeOH–TBME 0.02–0.75 0.53
4 MeOH–2-MeTHF 0.06–0.80 0.65
5 MeOH–DMC 0.04–0.88 0.55
6 i-PrOH–EtOAc 0.02–0.84 0.49
a 10% modiﬁer in bulk solvent.































































(0.02–0.94). This may translate to an improved achievable
chromatographic resolution with the CPME-based eluent when
employed in a puriﬁcation scenario. (ii) Both the TBME- and
2-MeTHF-based eluents have comparatively greater compression
in their data sets. For example, for 2-MeTHF, 50% of the total
data is found in the 0.65–0.80 Rf range. This truncation of the
higher Rf quadrants (median Rf = 0.53 and 0.65, respectively)
suggests a lower utility for replacing CH2Cl2 and, in addition,
the reduced Rf range (0.02–0.75 and 0.06–0.80, respectively)
suggests resolution is likely to be poorer. (iii) The DMC and
EtOAc data also established excellent distribution with good Rf
range coverage (0.04–0.88 and 0.02–0.84, respectively) and
good homogeneity of the data sets (median Rf = 0.55 and 0.49,
respectively). Overall, based on this analysis it would appear that
MeOH–CPME offers the highest potential for replacement of
MeOH–CH2Cl2 in this context, however, MeOH–DMC and
i-PrOH–EtOAc are also likely to offer considerable utility.
Based on the box plot analysis above, we sought to further
analyse our data in order to establish if more in depth corre-
lations existed between the selected replacement solvents and
CH2Cl2. Accordingly, we employed Spotﬁre
10 to survey our data
for relationships between the data sets for each binary eluent
system. This analysis revealed even stronger support for CPME
as a candidate for replacement of CH2Cl2. Fig. 5 shows how the
data for MeOH–CH2Cl2 correlates with the data for MeOH–
CPME at the 10% modiﬁer level.
We were pleased to note a strong correlation between the data
sets from this analysis with an R2 of 0.71. Similar trends were
observed for the 5% and 20% modiﬁer data sets (R2 = 0.55 and
0.65, respectively). Interestingly, as shown in Fig. 5, the majority
of outliers were acidic in nature, for example compounds 5, 10,
20, 37, 86, and 91. An additional trend was observed for the
acidic compounds where, in general and over the entire data set,
these seem to run to higher Rf in MeOH–CPME mixtures than in
equivalent MeOH–CH2Cl2 mixtures. By contrast, certain amine
derivatives, for example compounds 66, 79, 93, and 95, exhi-
bited lower Rf values in the MeOH–CPME eluent as compared
to MeOH–CH2Cl2. As predicted from the box plot analysis,
similar Spotﬁre-based mining of the other alternative eluents
revealed much poorer correlation with the MeOH–CH2Cl2 data
and, accordingly, these are less likely to function effectively as
direct replacements for CH2Cl2.‡ Based on all of the above, we
believe that MeOH–CPME is a potential viable replacement for
MeOH–CH2Cl2 within chromatographic puriﬁcation.
Conclusions
In summary, we have evaluated several alternative solvents as
potential replacements for CH2Cl2 as the bulk medium for
chromatographic puriﬁcation of a broad range of polar fragments
and more complex molecules with functionality frequently
encountered within Medicinal Chemistry programmes. Overall,
we have established several general trends that may assist in the
replacement of CH2Cl2 in MeOH-based puriﬁcation processes.
Speciﬁcally, based on our general analysis of the whole data set,
CPME would appear to offer considerable potential as a direct
replacement for CH2Cl2 in binary eluents using MeOH as the
modiﬁer with MeOH–DMC and i-PrOH–EtOAc also offering
some potential advantages. We have also observed some intri-
guing trends in relation to certain acidic and basic compounds,
which may be useful to laboratory practitioners. Overall, based
on the work detailed here and related emerging studies, we
believe that replacement of CH2Cl2 would not only be possible
but also practical, straightforward, and highly beneﬁcial for
sustainable practice in industry and academia.
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